Moderna
North America, Massachusetts, United States, Cambridge
Description
Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.
Investor Profile
Moderna has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 67% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Post Ipo Equity, Debt Financing rounds (top funding stages).
- Majority of deals are located in United States, Germany.
- Strong thematic focus on Biotechnology, Therapeutics, Artificial Intelligence (AI).
Stage Focus
- Series B (33%)
- Post Ipo Equity (33%)
- Debt Financing (17%)
- Series Unknown (17%)
Country Focus
- United States (67%)
- Germany (17%)
Industry Focus
- Biotechnology
- Therapeutics
- Artificial Intelligence (Ai)
- Machine Learning
- Health Care
- Hedge Funds
- Medical
- Genetics
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
